Intellia Therapeutics, Inc.

URI: https://gptkb.org/entity/Intellia_Therapeutics,_Inc.
GPTKB entity
Statements (27)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:CEO gptkb:John_Leonard
gptkbp:collaboratesWith gptkb:Novartis
gptkb:Regeneron_Pharmaceuticals
gptkbp:focusesOn CRISPR gene editing
gptkbp:foundedIn 2014
gptkbp:founder gptkb:Jennifer_Doudna
gptkb:Derrick_Rossi
gptkb:Rodger_Novak
gptkbp:headquartersLocation gptkb:Cambridge,_Massachusetts,_United_States
https://www.w3.org/2000/01/rdf-schema#label Intellia Therapeutics, Inc.
gptkbp:industry gptkb:biotechnology
gptkbp:mission develop curative genome editing treatments
gptkbp:notableAchievement first to demonstrate in vivo CRISPR gene editing in humans
gptkbp:notableProduct gptkb:NTLA-2001
gptkb:NTLA-2002
gptkb:NTLA-5001
gptkbp:numberOfEmployees approximately 400 (2023)
gptkbp:publiclyTraded true
gptkbp:servesArea worldwide
gptkbp:specializesIn ex vivo gene editing
in vivo gene editing
gptkbp:stockSymbol gptkb:NTLA
gptkbp:tradedOn gptkb:NASDAQ
gptkbp:website https://www.intelliatx.com/
gptkbp:bfsParent gptkb:NTLA
gptkbp:bfsLayer 6